Chimeric Therapeutics
(OTCPK:CHMMF)

Chimeric Therapeutics Stock (OTC:CHMMF), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Analyst Ratings for Chimeric Therapeutics

Buy NowGet Alert
No data available to display

FAQ

Q

What is the target price for Chimeric Therapeutics (CHMMF)?

A

There is no price target for Chimeric Therapeutics.

Q

What is the most recent analyst rating for Chimeric Therapeutics (CHMMF)?

A

There is no analyst for Chimeric Therapeutics.

Q

When was the last upgrade for Chimeric Therapeutics (CHMMF)?

A

There is no last upgrade for Chimeric Therapeutics.

Q

When was the last downgrade for Chimeric Therapeutics (CHMMF)?

A

There is no last downgrade for Chimeric Therapeutics.

Q

When is the next analyst rating going to be posted or updated for Chimeric Therapeutics (CHMMF)?

A

There is no next analyst rating for Chimeric Therapeutics.

Q

Is the Analyst Rating Chimeric Therapeutics (CHMMF) correct?

A

There is no next analyst rating for Chimeric Therapeutics.

Browse analyst ratings and price targets on all stocks.